MedPath
NMPA Approval

Meropenem for Injection

国药准字H20217096

November 2, 2021

国药准字H20113022

Drug Information

注射用美罗培南

注射剂

1.0g(按C17H25N3O5S计)

化学药品

November 2, 2021

Company Information

Applicant Company

深圳市光明区马田街道马山头社区钟表基地格雅科技大厦1栋707

Manufacturing Company

深圳市光明新区公明办事处将石社区下石家第二工业区D栋

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用美罗培南 - NMPA 批准文号 | MedPath